| http://dbpedia.org/ontology/abstract
|
Amylin Pharmaceuticals ist ein biopharmaze … Amylin Pharmaceuticals ist ein biopharmazeutisches Unternehmen mit Sitz in San Diego, das 1987 gegründet wurde. Es beschäftigt sich mit der Feststellung, Entwicklung und Vermarktung von Arzneimittelkandidaten für die Behandlung von Diabetes, Fettleibigkeit und anderen Krankheiten. Amylin produziert zurzeit zwei Medikamente: Symlin und Byetta. Das Unternehmen produziert auch ein Arzneimittel, das auf Leptin basiert. ein Arzneimittel, das auf Leptin basiert.
, Amylin Pharmaceuticals est un groupe pharm … Amylin Pharmaceuticals est un groupe pharmaceutique basé à San Diego et fondé en 1987, spécialisé dans la recherche, le développement et la commercialisation de médicaments destinés essentiellement au traitement du diabète, de l'obésité et des troubles cardiovasculaires. Le 30 juin 2012, Bristol-Myers annonce le rachat d'Amylin Pharmaceuticals pour 5,3 milliards de $. Le titre (code AMLN) est retiré de la cotation.tre (code AMLN) est retiré de la cotation.
, Amylin Pharmaceuticals is a biopharmaceuti … Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company was engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Amylin produced three drugs: Symlin (pramlintide acetate), Byetta (exenatide) and Bydureon (exenatide extended-release).and Bydureon (exenatide extended-release).
, Amylin Pharmaceuticals è una società biofa … Amylin Pharmaceuticals è una società biofarmaceutica con sede a San Diego, California, che è stata fondata nel 1987. Attualmente, la Amylin produce due farmaci, il Symlin (acetato di pramlintide) e il Byetta (exenatide). La Amylin sta sviluppando la produzione di un farmaco basato sulla leptina. Amylin fa parte della NASDAQ-100.leptina. Amylin fa parte della NASDAQ-100.
|
| http://dbpedia.org/ontology/assets
|
1.87E9
|
| http://dbpedia.org/ontology/fate
|
Acquired byBristol-Myers SquibbandAstraZeneca
|
| http://dbpedia.org/ontology/foundingYear
|
1987
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/San_Diego%2C_California +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
1300
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Exenatide +
, http://dbpedia.org/resource/Pramlintide +
|
| http://dbpedia.org/ontology/revenue
|
6.51E8
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Amylin_Pharmaceuticals.svg?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Subsidiary +
|
| http://dbpedia.org/ontology/wikiPageID
|
11635760
|
| http://dbpedia.org/ontology/wikiPageLength
|
14472
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1096884092
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/LifeScan +
, http://dbpedia.org/resource/Johnson_&_Johnson +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1987 +
, http://dbpedia.org/resource/Category:Companies_based_in_San_Diego +
, http://dbpedia.org/resource/Category:1992_initial_public_offerings +
, http://dbpedia.org/resource/Category:Bristol_Myers_Squibb +
, http://dbpedia.org/resource/Diabetes_mellitus_type_2 +
, http://dbpedia.org/resource/Hybritech +
, http://dbpedia.org/resource/United_States_Dollar +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1987 +
, http://dbpedia.org/resource/Ohio +
, http://dbpedia.org/resource/Gila_monster +
, http://dbpedia.org/resource/Leptin +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Obesity +
, http://dbpedia.org/resource/Category:Biopharmaceutical_companies +
, http://dbpedia.org/resource/AstraZeneca +
, http://dbpedia.org/resource/Bristol-Myers_Squibb +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/Glucagon +
, http://dbpedia.org/resource/San_Diego +
, http://dbpedia.org/resource/Metreleptin +
, http://dbpedia.org/resource/Hypoglycemia +
, http://dbpedia.org/resource/San_Diego%2C_California +
, http://dbpedia.org/resource/Category:2012_mergers_and_acquisitions +
, http://dbpedia.org/resource/Diabetes_mellitus +
, http://dbpedia.org/resource/Category:Defunct_pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Pramlintide +
, http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_disestablished_in_2012 +
, http://dbpedia.org/resource/Amylin +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Diabetes_mellitus_type_1 +
, http://dbpedia.org/resource/NASDAQ +
, http://dbpedia.org/resource/Category:AstraZeneca +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_California +
, http://dbpedia.org/resource/Food_and_Drug_Administration +
, http://dbpedia.org/resource/Exenatide +
, http://dbpedia.org/resource/Pramlintide_acetate +
, http://dbpedia.org/resource/GLP-1 +
, http://dbpedia.org/resource/Insulin +
, http://dbpedia.org/resource/Subsidiary +
, http://dbpedia.org/resource/Diabetes +
|
| http://dbpedia.org/property/assets
|
1.87E9
|
| http://dbpedia.org/property/equity
|
US$ million
|
| http://dbpedia.org/property/fate
|
Acquired by Bristol-Myers Squibb and AstraZeneca
|
| http://dbpedia.org/property/foundation
|
1987
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Daniel M. Bradbury
|
| http://dbpedia.org/property/location
|
San Diego, California, United States
|
| http://dbpedia.org/property/logo
|
Amylin Pharmaceuticals.svg
|
| http://dbpedia.org/property/logoSize
|
200
|
| http://dbpedia.org/property/name
|
Amylin Pharmaceuticals, Inc.
|
| http://dbpedia.org/property/netIncome
|
US$ million
|
| http://dbpedia.org/property/numEmployees
|
1300
|
| http://dbpedia.org/property/products
|
Bydureon
, Symlin
, Byetta
|
| http://dbpedia.org/property/revenue
|
6.51E8
|
| http://dbpedia.org/property/subsid
|
Amylin Ohio LLC
|
| http://dbpedia.org/property/tradedAs
|
NASDAQ: AMLN
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Subsidiary +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Portal +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Template:Color +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:End_date_and_age +
, http://dbpedia.org/resource/Template:Citation_needed +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Increase +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Decrease +
|
| http://dbpedia.org/property/wordnet type
|
http://www.w3.org/2006/03/wn/wn20/instances/synset-company-noun-1 +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1987 +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_disestablished_in_2012 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1987 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Biopharmaceutical_companies +
, http://dbpedia.org/resource/Category:Defunct_pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Category:Bristol_Myers_Squibb +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_California +
, http://dbpedia.org/resource/Category:1992_initial_public_offerings +
, http://dbpedia.org/resource/Category:AstraZeneca +
, http://dbpedia.org/resource/Category:2012_mergers_and_acquisitions +
, http://dbpedia.org/resource/Category:Companies_based_in_San_Diego +
, http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://schema.org/sameAs
|
http://viaf.org/viaf/152673906 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Amylin_Pharmaceuticals?oldid=1096884092&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Amylin_Pharmaceuticals.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Amylin_Pharmaceuticals +
|
| http://xmlns.com/foaf/0.1/name
|
Amylin Pharmaceuticals, Inc.
|
| owl:sameAs |
http://yago-knowledge.org/resource/Amylin_Pharmaceuticals +
, http://fa.dbpedia.org/resource/%D8%B4%D8%B1%DA%A9%D8%AA_%D8%AF%D8%A7%D8%B1%D9%88%DB%8C%DB%8C_%D8%A2%D9%85%DB%8C%D9%84%DB%8C%D9%86 +
, http://de.dbpedia.org/resource/Amylin_Pharmaceuticals +
, http://viaf.org/viaf/152673906 +
, https://global.dbpedia.org/id/4UF5i +
, http://it.dbpedia.org/resource/Amylin_Pharmaceuticals +
, http://www.wikidata.org/entity/Q482044 +
, http://fr.dbpedia.org/resource/Amylin_Pharmaceuticals +
, http://dbpedia.org/resource/Amylin_Pharmaceuticals +
, http://rdf.freebase.com/ns/m.02rm8_8 +
|
| rdf:type |
http://dbpedia.org/class/yago/WikicatCompaniesListedOnNASDAQ +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/WikicatCompaniesInTheNASDAQ-100Index +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn1987 +
, http://dbpedia.org/class/yago/WikicatCompaniesBasedInCalifornia +
, http://schema.org/Organization +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/Company108058098 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/class/yago/DrugCompany108002578 +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompaniesOfTheUnitedStates +
, http://dbpedia.org/class/yago/WikicatCompaniesBasedInSanDiego%2CCalifornia +
, http://umbel.org/umbel/rc/Business +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompanies +
|
| rdfs:comment |
Amylin Pharmaceuticals is a biopharmaceuti … Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company was engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Amylin produced three drugs: Symlin (pramlintide acetate), Byetta (exenatide) and Bydureon (exenatide extended-release).and Bydureon (exenatide extended-release).
, Amylin Pharmaceuticals ist ein biopharmaze … Amylin Pharmaceuticals ist ein biopharmazeutisches Unternehmen mit Sitz in San Diego, das 1987 gegründet wurde. Es beschäftigt sich mit der Feststellung, Entwicklung und Vermarktung von Arzneimittelkandidaten für die Behandlung von Diabetes, Fettleibigkeit und anderen Krankheiten. Amylin produziert zurzeit zwei Medikamente: Symlin und Byetta. Das Unternehmen produziert auch ein Arzneimittel, das auf Leptin basiert. ein Arzneimittel, das auf Leptin basiert.
, Amylin Pharmaceuticals est un groupe pharm … Amylin Pharmaceuticals est un groupe pharmaceutique basé à San Diego et fondé en 1987, spécialisé dans la recherche, le développement et la commercialisation de médicaments destinés essentiellement au traitement du diabète, de l'obésité et des troubles cardiovasculaires. Le 30 juin 2012, Bristol-Myers annonce le rachat d'Amylin Pharmaceuticals pour 5,3 milliards de $. Le titre (code AMLN) est retiré de la cotation.tre (code AMLN) est retiré de la cotation.
, Amylin Pharmaceuticals è una società biofa … Amylin Pharmaceuticals è una società biofarmaceutica con sede a San Diego, California, che è stata fondata nel 1987. Attualmente, la Amylin produce due farmaci, il Symlin (acetato di pramlintide) e il Byetta (exenatide). La Amylin sta sviluppando la produzione di un farmaco basato sulla leptina. Amylin fa parte della NASDAQ-100.leptina. Amylin fa parte della NASDAQ-100.
|
| rdfs:label |
Amylin Pharmaceuticals
|
